Loading clinical trials...
Loading clinical trials...
Aphasia is an acquired impairment of language, that commonly results from damage to language areas in the brain (typically the left side of the brain). This impairment is seen in many aspects of langu...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University of Arizona
NCT07036406 · Aphasia, Aphasia Following Cerebral Infarction, and more
NCT05283265 · Language Disorders
NCT06739967 · Primary Progressive Aphasia(PPA)
NCT07369960 · Developmental Delay Disorder, Repetitive Transcranial Magnetic Stimulation (rTMS), and more
NCT04715399 · Frontotemporal Degeneration(FTD), Primary Progressive Aphasia(PPA), and more
University of Arizona
Tucson, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions